Carlo Allegri/Reuters
- The Food and Drug Administration on Friday approved a new nasal spray to treat migraines.
- The spray will be available in July and is designed to treat migraines in 15 minutes.
- Pfizer acquired the drug when it bought out Biohaven Pharmaceuticals last year for $11.6 billion.
The Food and Drug Administration on Friday approved Zavzpret, a new nasal spray designed to treat migraines in just 15 minutes.
The drug, which Pfizer acquired when it bought out Biohaven Pharmaceuticals last year for $11.6 billion, will provide an alternative to oral migraine medication, NBC News reported.